Puma Biotech: Q4 Earnings Snapshot

March 3, 2022 GMT

LOS ANGELES (AP) _ Puma Biotechnology Inc. (PBYI) on Thursday reported earnings of $4.2 million in its fourth quarter.

On a per-share basis, the Los Angeles-based company said it had net income of 10 cents.

The biopharmaceutical company posted revenue of $55.4 million in the period.

For the year, the company reported a loss of $29.1 million, or 72 cents per share. Revenue was reported as $253.2 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PBYI at https://www.zacks.com/ap/PBYI